|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4470461A
(en)
|
1982-09-30 |
1984-09-11 |
Phillips Petroleum Company |
Organic nitro compounds as cosurfactants in enhanced oil recovery processes
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
|
EP0368684B2
(en)
|
1988-11-11 |
2004-09-29 |
Medical Research Council |
Cloning immunoglobulin variable domain sequences.
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
AU649066B2
(en)
|
1990-07-25 |
1994-05-12 |
Syngene, Inc. |
Circular extension for generating multiple nucleic acid complements
|
|
GB9022788D0
(en)
|
1990-10-19 |
1990-12-05 |
Cortecs Ltd |
Pharmaceutical formulations
|
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
|
GB9114948D0
(en)
|
1991-07-11 |
1991-08-28 |
Pfizer Ltd |
Process for preparing sertraline intermediates
|
|
FI941572A7
(fi)
|
1991-10-07 |
1994-05-27 |
Oncologix Inc |
Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenete lmä
|
|
US5858784A
(en)
|
1991-12-17 |
1999-01-12 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol- and liposome-based delivery
|
|
US5633234A
(en)
|
1993-01-22 |
1997-05-27 |
The Johns Hopkins University |
Lysosomal targeting of immunogens
|
|
ES2162863T3
(es)
|
1993-04-29 |
2002-01-16 |
Unilever Nv |
Produccion de anticuerpos o fragmentos (funcionalizados) de los mismos derivados de inmunoglobulinas de cadena pesada de camelidae.
|
|
US5773244A
(en)
|
1993-05-19 |
1998-06-30 |
Regents Of The University Of California |
Methods of making circular RNA
|
|
FR2709309B1
(fr)
|
1993-08-25 |
1995-11-10 |
Centre Nat Rech Scient |
Compositions cellulaires, préparation et utilisations thérapeutiques.
|
|
US5631236A
(en)
|
1993-08-26 |
1997-05-20 |
Baylor College Of Medicine |
Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
|
|
US5641875A
(en)
|
1993-09-30 |
1997-06-24 |
University Of Pennsylvania |
DNA encoding chimeric IgG Fc receptor
|
|
US5639642A
(en)
|
1994-06-16 |
1997-06-17 |
Novo Nordisk A/S |
Synthetic leader peptide sequences
|
|
US6300090B1
(en)
|
1994-07-29 |
2001-10-09 |
The Rockefeller University |
Methods of use of viral vectors to deliver antigen to dendritic cells
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
US5766903A
(en)
|
1995-08-23 |
1998-06-16 |
University Technology Corporation |
Circular RNA and uses thereof
|
|
US6734014B1
(en)
|
1996-02-08 |
2004-05-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Methods and compositions for transforming dendritic cells and activating T cells
|
|
US6194204B1
(en)
|
1996-08-02 |
2001-02-27 |
Center For Blood Research, Inc. |
Enrichment of dendritic cells from blood
|
|
AU2872199A
(en)
|
1998-02-20 |
1999-09-06 |
Rockefeller University, The |
Apoptotic cell-mediated antigen presentation to dendritic cells
|
|
US6210931B1
(en)
|
1998-11-30 |
2001-04-03 |
The United States Of America As Represented By The Secretary Of Agriculture |
Ribozyme-mediated synthesis of circular RNA
|
|
WO2001083713A2
(en)
|
2000-04-28 |
2001-11-08 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
The use of tolerogenic dendritic cells for enhancing tolerogenicity in a host and methods for making the same
|
|
ATE338124T1
(de)
|
2000-11-07 |
2006-09-15 |
Hope City |
Cd19-spezifische umgezielte immunzellen
|
|
US8709412B2
(en)
|
2001-06-29 |
2014-04-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulation of TIM receptor activity in combination with cytoreductive therapy
|
|
AU2003219805B2
(en)
|
2002-02-15 |
2009-06-04 |
Eisai Inc. |
Electroporation methods for introducing bioactive agents into cells
|
|
US20080254027A1
(en)
|
2002-03-01 |
2008-10-16 |
Bernett Matthew J |
Optimized CD5 antibodies and methods of using the same
|
|
CA2478047C
(en)
|
2002-03-01 |
2014-01-21 |
Immunomedics, Inc. |
Rs7 antibodies
|
|
EP1567014B1
(en)
|
2002-12-04 |
2011-09-28 |
Baylor Research Institute |
Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors
|
|
US8007805B2
(en)
|
2003-08-08 |
2011-08-30 |
Paladin Labs, Inc. |
Chimeric antigens for breaking host tolerance to foreign antigens
|
|
WO2005019429A2
(en)
|
2003-08-22 |
2005-03-03 |
Potentia Pharmaceuticals, Inc. |
Compositions and methods for enhancing phagocytosis or phagocyte activity
|
|
US7709625B2
(en)
|
2004-06-10 |
2010-05-04 |
The Board Of Regents Of The University Of Texas |
Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy
|
|
ZA200704252B
(en)
|
2004-10-25 |
2009-09-30 |
Cellerant Therapeutics Inc |
Methods of expanding myeloid cell populations and uses thereof
|
|
US20060188891A1
(en)
|
2005-02-23 |
2006-08-24 |
Bickmore William D Jr |
Methods and apparatus for controlling DNA amplification
|
|
US20060257359A1
(en)
|
2005-02-28 |
2006-11-16 |
Cedric Francois |
Modifying macrophage phenotype for treatment of disease
|
|
US20090191202A1
(en)
|
2005-09-29 |
2009-07-30 |
Jamieson Catriona Helen M |
Methods for manipulating phagocytosis mediated by CD47
|
|
US7926300B2
(en)
|
2005-11-18 |
2011-04-19 |
Cree, Inc. |
Adaptive adjustment of light output of solid state lighting panels
|
|
AU2007232356A1
(en)
|
2006-04-03 |
2007-10-11 |
Keele University |
Targeted therapy
|
|
EP2046347A2
(en)
|
2006-07-20 |
2009-04-15 |
Gourmetceuticals, LLC |
Phosphorylated glucomannan polysaccharide for receptor mediated activation and maturation of monocyte-derived dendritic cells
|
|
US7833789B2
(en)
|
2006-08-01 |
2010-11-16 |
Fondazione Centro San Raffaele Del Monte Tabor |
Monocyte cell
|
|
CA2672581A1
(en)
|
2006-12-14 |
2008-06-19 |
Forerunner Pharma Research Co., Ltd. |
Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same
|
|
ES2582340T3
(es)
|
2008-01-15 |
2016-09-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Métodos para manipular fagocitosis mediada por CD47
|
|
WO2010010119A1
(en)
|
2008-07-22 |
2010-01-28 |
Ablynx Nv |
Amino acid sequences directed against multitarget scavenger receptors and polypeptides
|
|
RU2011111640A
(ru)
|
2008-08-29 |
2012-10-10 |
Симфоген А/С (Dk) |
Антитела против cd5
|
|
CA2738031C
(en)
|
2008-09-22 |
2022-11-29 |
Baylor College Of Medicine |
Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
|
|
EP2248903A1
(en)
|
2009-04-29 |
2010-11-10 |
Universitat Autònoma De Barcelona |
Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages
|
|
EP2332994A1
(en)
|
2009-12-09 |
2011-06-15 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Trispecific therapeutics against acute myeloid leukaemia
|
|
US9101674B2
(en)
|
2010-03-29 |
2015-08-11 |
Vib Vzw |
Targeting and in vivo imaging of tumor-associated macrophages
|
|
US20110287038A1
(en)
|
2010-04-16 |
2011-11-24 |
Kevin Slawin |
Method for treating solid tumors
|
|
WO2012005763A1
(en)
|
2010-07-06 |
2012-01-12 |
The Scripps Research Institute |
Use of myeloid-like progenitor cell populations to treat tumors
|
|
ES2602743T3
(es)
|
2010-09-08 |
2017-02-22 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Receptores de antígenos quiméricos con una región bisagra optimizada
|
|
JP5861191B2
(ja)
|
2010-09-30 |
2016-02-16 |
国立大学法人 熊本大学 |
ミエロイド系血液細胞の製造方法
|
|
DE102010047966A1
(de)
|
2010-10-08 |
2012-04-12 |
Rheinmetall Waffe Munition Gmbh |
Nicht-letale Munition zur Unschädlichmachung von Zielen
|
|
RU2013154295A
(ru)
*
|
2011-06-08 |
2015-07-20 |
Шир Хьюман Дженетик Терапис, Инк. |
КОМПОЗИЦИИ ЛИПИДНЫХ НАНОЧАСТИЦ И СПОСОБЫ ДЛЯ ДОСТАВКИ мРНК
|
|
WO2013051718A1
(ja)
|
2011-10-07 |
2013-04-11 |
国立大学法人三重大学 |
キメラ抗原受容体
|
|
US9149519B2
(en)
|
2012-01-17 |
2015-10-06 |
New York University |
Chimeric human immunodeficiency virus type 1 (HIV-1) with enhanced dendritic cell and macrophage tropism comprising the simian immunodeficiency virus (SIV) minimal Vpx packaging domain
|
|
US20140140989A1
(en)
|
2012-02-06 |
2014-05-22 |
Inhibrx Llc |
Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof
|
|
KR102100388B1
(ko)
|
2012-02-06 |
2020-04-13 |
인히브릭스, 인크. |
Cd47 항체 및 그 사용 방법
|
|
WO2013123088A1
(en)
|
2012-02-14 |
2013-08-22 |
Loma Linda University |
Agents and method for treating inflammation-related conditions and diseases
|
|
EP2639313A1
(en)
|
2012-03-14 |
2013-09-18 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
High-resolution transcriptome of human macrophages
|
|
BR112014029417B1
(pt)
|
2012-05-25 |
2023-03-07 |
Cellectis |
Método ex vivo para a preparação de células t para imunoterapia
|
|
CN103483452B
(zh)
|
2012-06-12 |
2021-08-13 |
上海细胞治疗集团有限公司 |
双信号独立的嵌合抗原受体及其用途
|
|
US9382329B2
(en)
*
|
2012-08-14 |
2016-07-05 |
Ibc Pharmaceuticals, Inc. |
Disease therapy by inducing immune response to Trop-2 expressing cells
|
|
MX370148B
(es)
|
2012-10-02 |
2019-12-03 |
Memorial Sloan Kettering Cancer Center |
Composiciones y su uso para inmunoterapia.
|
|
BR112015013431A2
(pt)
|
2012-12-12 |
2017-11-14 |
Vasculox Inc |
anticorpos monoclonais ou respectivos fragmentos ligantes de antígenos, composição farmacêutica, e usos de anticorpo monoclonal ou respectivo fragmento ligante de antígenos
|
|
US9221908B2
(en)
|
2012-12-12 |
2015-12-29 |
Vasculox, Inc. |
Therapeutic CD47 antibodies
|
|
NZ710695A
(en)
|
2013-02-06 |
2020-05-29 |
Inhibrx Inc |
Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereof
|
|
SE537429C2
(sv)
|
2013-02-14 |
2015-04-28 |
Scania Cv Ab |
Samtidig skattning av åtminstone massa och rullmotstånd förett fordon
|
|
EP2970985A1
(en)
|
2013-03-14 |
2016-01-20 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to modify cells for therapeutic objectives
|
|
WO2014145252A2
(en)
|
2013-03-15 |
2014-09-18 |
Milone Michael C |
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
|
|
CN105873952A
(zh)
|
2013-10-31 |
2016-08-17 |
弗莱德哈钦森癌症研究中心 |
经修饰的造血干细胞/祖细胞和非t效应细胞及其用途
|
|
NZ759969A
(en)
*
|
2013-12-20 |
2022-12-23 |
Fred Hutchinson Cancer Center |
Tagged chimeric effector molecules and receptors thereof
|
|
AU2014371934B2
(en)
*
|
2013-12-25 |
2020-01-23 |
Daiichi Sankyo Company, Limited |
Anti-TROP2 antibody-drug conjugate
|
|
CN106456749B
(zh)
|
2014-03-11 |
2021-03-30 |
小利兰·斯坦福大学托管委员会 |
抗SIRPα抗体和双特异性巨噬细胞增强型抗体
|
|
US20170233452A1
(en)
|
2014-04-23 |
2017-08-17 |
Immusoft Corporation |
Chimeric antigen receptors specific to avb6 integrin and methods of use thereof to treat cancer
|
|
CN104004095B
(zh)
|
2014-06-04 |
2016-11-23 |
博生吉医药科技(苏州)有限公司 |
一种cd7纳米抗体、其编码序列及应用
|
|
US10407683B2
(en)
|
2014-07-16 |
2019-09-10 |
Modernatx, Inc. |
Circular polynucleotides
|
|
US10544201B2
(en)
|
2014-07-31 |
2020-01-28 |
Cellectis |
ROR1 specific multi-chain chimeric antigen receptor
|
|
MX2017002205A
(es)
|
2014-08-19 |
2017-08-21 |
Novartis Ag |
Receptor quimerico de antigeno (car) anti-cd123 para uso en el tratamiento de cancer.
|
|
DK4074735T3
(da)
|
2014-08-28 |
2025-07-14 |
Bioatla Inc |
Betinget aktive kimæriske antigenreceptorer til modificerede t-celler
|
|
CA2972714A1
(en)
|
2014-09-09 |
2016-03-17 |
Unum Therapeutics |
Chimeric receptors and uses thereof in immune therapy
|
|
CA2961950A1
(en)
|
2014-09-28 |
2016-03-31 |
The Regents Of The University Of California |
Modulation of stimulatory and non-stimulatory myeloid cells
|
|
BR112017007003A2
(pt)
|
2014-10-07 |
2017-12-19 |
Cellectis |
método para modulação de atividade de células imunes induzidas por car
|
|
MA41538A
(fr)
|
2014-10-17 |
2017-12-26 |
Baylor College Medicine |
Cellules immunitaires bipartites et tripartites de signalisation
|
|
KR20170074235A
(ko)
|
2014-10-31 |
2017-06-29 |
메사추세츠 인스티튜트 오브 테크놀로지 |
면역 세포로의 생체분자의 전달
|
|
EP3221358B1
(en)
|
2014-11-18 |
2021-07-21 |
Janssen Pharmaceutica, N.V. |
Cd47 antibodies, methods, and uses
|
|
RU2021118125A
(ru)
*
|
2014-12-29 |
2022-04-06 |
Новартис Аг |
Способы получения экспрессирующих химерный антигенный рецептор клеток
|
|
WO2016126608A1
(en)
|
2015-02-02 |
2016-08-11 |
Novartis Ag |
Car-expressing cells against multiple tumor antigens and uses thereof
|
|
US10577669B2
(en)
|
2015-02-11 |
2020-03-03 |
Loma Linda University |
Method for utilizing engineered dendritic cells to induce gut-homing regulatory T cells and treat gut inflammation
|
|
US20170151281A1
(en)
|
2015-02-19 |
2017-06-01 |
Batu Biologics, Inc. |
Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer
|
|
KR102624023B1
(ko)
|
2015-02-24 |
2024-01-11 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
결합-촉발된 전사 스위치 및 이들의 이용 방법
|
|
JP7237449B2
(ja)
|
2015-02-27 |
2023-03-13 |
アイセル・ジーン・セラピューティクス・エルエルシー |
血液系腫瘍を標的としたキメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法
|
|
US9777064B2
(en)
|
2015-03-17 |
2017-10-03 |
Chimera Bioengineering, Inc. |
Smart CAR devices, DE CAR polypeptides, side CARs and uses thereof
|
|
US10786549B2
(en)
|
2015-04-23 |
2020-09-29 |
Baylor College Of Medicine |
CD5 chimeric antigen receptor for adoptive T cell therapy
|
|
CN114425077A
(zh)
|
2015-05-18 |
2022-05-03 |
起源生物医药公司 |
Sirp多肽组合物和使用方法
|
|
US10434153B1
(en)
|
2015-05-20 |
2019-10-08 |
Kim Leslie O'Neill |
Use of car and bite technology coupled with an scFv from an antibody against human thymidine kinase 1 to specifically target tumors
|
|
GB201509413D0
(en)
|
2015-06-01 |
2015-07-15 |
Ucl Business Plc |
Fusion protein
|
|
EP3302558A4
(en)
|
2015-06-01 |
2019-01-16 |
The Rockefeller University |
ANTI-TUMOR MEDIUM AND METHOD OF USE
|
|
WO2017015553A1
(en)
|
2015-07-22 |
2017-01-26 |
University Of Washington |
Compositions and methods for producing pro-inflammatory macrophages
|
|
IL315940A
(en)
|
2015-07-28 |
2024-11-01 |
Univ Pennsylvania |
Altered monocytes/macrophages expressing chimeric antigen receptors and their uses
|
|
CA2993429A1
(en)
|
2015-07-31 |
2017-02-09 |
Tarveda Therapeutics, Inc. |
Compositions and methods for immuno-oncology therapies
|
|
AU2016304794B2
(en)
|
2015-08-07 |
2021-07-15 |
ALX Oncology Inc. |
Constructs having a SIRP-alpha domain or variant thereof
|
|
US11352439B2
(en)
|
2015-08-13 |
2022-06-07 |
Kim Leslie O'Neill |
Macrophage CAR (MOTO-CAR) in immunotherapy
|
|
WO2017025944A2
(en)
|
2015-08-13 |
2017-02-16 |
Brigham Young University |
Macrophage car (moto-car) in imunotherapy
|
|
EP3347026A4
(en)
|
2015-09-09 |
2019-05-08 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
GENEMANIPULATION OF MACROPHAGES FOR IMMUNOTHERAPY
|
|
ES3063691T3
(en)
|
2015-09-22 |
2026-04-20 |
Univ Wuerzburg J Maximilians |
A method for high level and stable gene transfer in lymphocytes
|
|
CN108472317A
(zh)
|
2015-11-09 |
2018-08-31 |
爱普瑞希斯有限公司 |
修饰免疫细胞及其用途
|
|
US10946042B2
(en)
|
2015-12-01 |
2021-03-16 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for selective phagocytosis of human cancer cells
|
|
EP3202783A1
(en)
|
2016-02-02 |
2017-08-09 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Engineered antigen presenting cells and uses thereof
|
|
WO2017133175A1
(en)
|
2016-02-04 |
2017-08-10 |
Nanjing Legend Biotech Co., Ltd. |
Engineered mammalian cells for cancer therapy
|
|
US12220451B2
(en)
|
2016-02-04 |
2025-02-11 |
Duke University |
Cell-based vaccine compositions and methods of use
|
|
US9820350B2
(en)
|
2016-02-19 |
2017-11-14 |
Cooper Technologies Company |
Configurable lighting system
|
|
US20180186855A1
(en)
|
2016-03-23 |
2018-07-05 |
Alector Llc |
Chimeric receptors and methods of use thereof
|
|
KR20230148844A
(ko)
|
2016-03-29 |
2023-10-25 |
유니버시티 오브 써던 캘리포니아 |
암을 표적하는 키메라 항원 수용체
|
|
WO2017184553A1
(en)
|
2016-04-18 |
2017-10-26 |
Baylor College Of Medicine |
Cancer gene therapy targeting cd47
|
|
US10875919B2
(en)
|
2016-04-26 |
2020-12-29 |
Alector Llc |
Chimeric receptors and methods of use thereof
|
|
WO2017213979A1
(en)
|
2016-06-06 |
2017-12-14 |
St. Jude Children's Research Hospital |
Anti-cd7 chimeric antigen receptor and method of use thereof
|
|
WO2018038684A1
(en)
|
2016-08-26 |
2018-03-01 |
Agency For Science, Technology And Research |
Macrophage stimulating protein receptor (or ron - recepteur d' origine nantais) antibodies and uses thereof
|
|
JOP20190009A1
(ar)
|
2016-09-21 |
2019-01-27 |
Alx Oncology Inc |
أجسام مضادة ضد بروتين ألفا منظم للإشارات وطرق استخدامها
|
|
AU2017335634A1
(en)
|
2016-09-27 |
2019-03-14 |
Cero Therapeutics, Inc. |
Chimeric engulfment receptor molecules
|
|
US20190263928A1
(en)
|
2016-09-30 |
2019-08-29 |
Baylor College Of Medicine |
Adaptive chimeric antigen receptor t-cell design
|
|
US11376332B2
(en)
|
2016-10-15 |
2022-07-05 |
Baylor College Of Medicine |
Platform for enhanced targeted delivery
|
|
WO2018073394A1
(en)
|
2016-10-19 |
2018-04-26 |
Cellectis |
Cell death inducing chimeric antigen receptors
|
|
EP3529276A4
(en)
|
2016-10-21 |
2020-06-17 |
Arch Oncology, Inc. |
CD47 THERAPEUTIC ANTIBODIES
|
|
US20190276549A1
(en)
|
2016-11-01 |
2019-09-12 |
Genmab B.V. |
Polypeptide variants and uses thereof
|
|
AU2017371070B2
(en)
|
2016-12-09 |
2025-01-02 |
Alector Llc |
Anti-SIRP-alpha antibodies and methods of use thereof
|
|
US20190336615A1
(en)
|
2017-01-27 |
2019-11-07 |
Silverback Therapeutics, Inc. |
Tumor targeting conjugates and methods of use thereof
|
|
AU2018226526B2
(en)
|
2017-02-28 |
2025-03-13 |
Affimed Gmbh |
Combination of an anti-CD16A antibody with a cytokine
|
|
CN117959418A
(zh)
|
2017-03-13 |
2024-05-03 |
波赛达治疗公司 |
用于选择性消除和替换造血干细胞的组合物和方法
|
|
US10415017B2
(en)
|
2017-05-17 |
2019-09-17 |
Thunder Biotech, Inc. |
Transgenic macrophages, chimeric antigen receptors, and associated methods
|
|
CN110944652A
(zh)
|
2017-06-12 |
2020-03-31 |
爱莫里大学 |
T细胞抗原靶向的嵌合抗原受体(car)以及在细胞疗法中的用途
|
|
TWI828625B
(zh)
|
2017-06-25 |
2024-01-11 |
美商西雅圖免疫公司 |
引導及導航控制蛋白質以及彼之製造及使用方法
|
|
BR112020001653A2
(pt)
|
2017-07-26 |
2020-07-21 |
Forty Seven, Inc. |
anticorpos anti-sirp-alfa e métodos relacionados
|
|
WO2019032624A1
(en)
|
2017-08-08 |
2019-02-14 |
Pionyr Immunotherapeutics, Inc. |
COMPOSITIONS AND METHODS FOR DEACTIVATING TREM1-EXPRESSING MESHLOID CELLS
|
|
EP3735460A4
(en)
|
2017-09-18 |
2021-08-11 |
Exuma Biotech Corp. |
METHODS AND COMPOSITIONS FOR THE GENETIC MODIFICATION AND EXPANSION OF LYMPHOCYTES AND THE REGULATION OF THE ACTIVITY OF THE LATTER
|
|
EP4714966A2
(en)
|
2017-09-26 |
2026-03-25 |
Cero Therapeutics Holdings, Inc. |
Chimeric engulfment receptor molecules and methods of use
|
|
WO2019070704A1
(en)
|
2017-10-02 |
2019-04-11 |
Georgia Tech Research Corporation |
METHODS AND COMPOSITIONS FOR ENGINEERING SYNTHESIS BIOLOGICAL SWITCHES FOR REMOTE CONTROL OF BIOLOGICAL ACTIVITY
|
|
GB201717974D0
(en)
|
2017-10-31 |
2017-12-13 |
Univ Court Of The Univ Of Aberdeen |
Modified receptors
|
|
CN109971716B
(zh)
|
2017-12-28 |
2023-08-01 |
上海细胞治疗研究院 |
自分泌cd47抗体的egfr特异性car-t细胞及其用途
|
|
SG11202007171PA
(en)
|
2018-02-02 |
2020-08-28 |
Univ Pennsylvania |
Modified monocytes/macrophages/dendritic cells expressing chimeric antigen receptors and uses in diseases and disorders associated with protein aggregates
|
|
GB2572005A
(en)
|
2018-03-16 |
2019-09-18 |
Univ Court Univ Of Edinburgh |
Macrophage-based therapy
|
|
MX2020010241A
(es)
|
2018-03-28 |
2020-10-16 |
Cero Therapeutics Inc |
Composiciones de inmunoterapia celular y usos de las mismas.
|
|
CA3093969A1
(en)
*
|
2018-03-28 |
2019-10-03 |
Cero Therapeutics, Inc. |
Expression vectors for chimeric engulfment receptors, genetically modified host cells, and uses thereof
|
|
WO2019191332A1
(en)
|
2018-03-28 |
2019-10-03 |
Cero Therapeutics, Inc. |
Chimeric engulfment receptors and uses thereof for neurodegenerative diseases
|
|
EP3774906A1
(en)
|
2018-03-28 |
2021-02-17 |
Cero Therapeutics, Inc. |
Chimeric tim4 receptors and uses thereof
|
|
WO2019201995A1
(en)
*
|
2018-04-20 |
2019-10-24 |
Medizinische Hochschule Hannover |
Chimeric antigen receptor and car-t cells that bind a herpes virus antigen
|
|
CN112312930A
(zh)
|
2018-05-02 |
2021-02-02 |
宾夕法尼亚大学董事会 |
磷脂酶a2受体嵌合自身抗体受体t细胞的组合物和方法
|
|
WO2020097193A1
(en)
|
2018-11-06 |
2020-05-14 |
The Regents Of The University Of California |
Chimeric antigen receptors for phagocytosis
|
|
GB201818110D0
(en)
|
2018-11-06 |
2018-12-19 |
Macrophox Ltd |
Monocytes for cancer targeting
|
|
CN113454117B
(zh)
|
2018-12-19 |
2025-07-04 |
宾夕法尼亚大学董事会 |
Cd2/5/7敲除抗-cd2/5/7嵌合抗原受体t细胞针对t细胞淋巴瘤和白血病的用途
|
|
US12018061B2
(en)
*
|
2019-03-08 |
2024-06-25 |
St Phi Therapeutics Co., Ltd. |
Chimeric endocytic receptors and method of use thereof
|
|
EP3962497A4
(en)
|
2019-04-30 |
2023-01-18 |
Myeloid Therapeutics, Inc. |
GENETICALLY ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
|
|
US20220001031A1
(en)
|
2019-04-30 |
2022-01-06 |
Myeloid Therapeutics, Inc. |
Engineered chimeric fusion protein compositions and methods of use thereof
|
|
US11026973B2
(en)
|
2019-04-30 |
2021-06-08 |
Myeloid Therapeutics, Inc. |
Engineered phagocytic receptor compositions and methods of use thereof
|
|
JP2022536684A
(ja)
|
2019-06-11 |
2022-08-18 |
マイエロイド・セラピューティクス，インコーポレーテッド |
マクロファージ特異的エンゲージャー組成物およびその使用方法
|
|
CN114981409A
(zh)
|
2019-09-03 |
2022-08-30 |
美洛德生物医药公司 |
用于基因组整合的方法和组合物
|
|
US10980836B1
(en)
|
2019-12-11 |
2021-04-20 |
Myeloid Therapeutics, Inc. |
Therapeutic cell compositions and methods of manufacturing and use thereof
|
|
WO2021119538A1
(en)
|
2019-12-11 |
2021-06-17 |
Myeloid Therapeutics, Inc. |
Therapeutic cell compositions and methods for manufacture and uses thereof
|
|
EP4161536A4
(en)
|
2020-06-04 |
2024-08-14 |
Carisma Therapeutics Inc. |
Novel constructs for chimeric antigen receptors
|
|
CA3187138A1
(en)
|
2020-06-26 |
2021-12-30 |
Carisma Therapeutics Inc. |
Mrna transfection of immune cells
|
|
WO2022036265A1
(en)
|
2020-08-14 |
2022-02-17 |
Cero Therapeutics, Inc. |
Chimeric tim receptors and uses thereof
|
|
AU2021350024A1
(en)
|
2020-09-24 |
2023-05-04 |
Flagship Pioneering Innovations V, Inc. |
Compositions and methods for inhibiting gene expression
|
|
EP4240367A4
(en)
|
2020-11-04 |
2024-10-16 |
Myeloid Therapeutics, Inc. |
MODIFIED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
|
|
CA3220164A1
(en)
*
|
2021-05-24 |
2022-12-01 |
Daniel Getts |
Engineered chimeric fusion protein compositions and methods of use thereof
|